Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (601-610 of 999) with videos related to

Pageof 100
Sort By:
Journal of Clinical Lipidology|September 11, 2019
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans AffairsSalim S Virani, Julia M Akeroyd, Sarah T Ahmed, et al.
Archives of Internal Medicine|July 13, 2006
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyAaron R Folsom, Lloyd E Chambless, Christie M Ballantyne, et al.
Neurology|May 3, 2019
ApoB, small-dense LDL-C, Lp(a), LpPLA<sub>2</sub> activity, and cognitive changeYashashwi Pokharel, Farah Mouhanna, Vijay Nambi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changesHuaizhu Wu, John R Rodgers, Xiao-Yuan Dai Perrard, et al.
Vascular Medicine (London, England)|March 10, 2010
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery diseaseWilliam R Hiatt, Alan T Hirsch, Mark A Creager, et al.
The EMBO Journal|February 3, 2007
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrinValeria V Orlova, Eun Young Choi, Changping Xie, et al.
The American Journal of Medicine|May 20, 2019
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health SystemXiaoming Jia, Mahmoud Al Rifai, David J Ramsey, et al.
Journal of the American College of Cardiology|September 10, 2017
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysDonald M Lloyd-Jones, Pamela B Morris, Christie M Ballantyne, et al.
Journal of the American College of Cardiology|January 17, 2015
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registryRavi S Hira, Kevin Kennedy, Vijay Nambi, et al.
Magnetic Resonance Imaging|August 8, 2022
Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery diseaseAnkita Sinharoy, Neeti Reddy, John Kent Lin, et al.
Pageof 100

Showing results (601-610 of 999) with videos related to

Sort By:
Pageof 100
Journal of Clinical Lipidology|September 11, 2019
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans AffairsSalim S Virani, Julia M Akeroyd, Sarah T Ahmed, et al.
Archives of Internal Medicine|July 13, 2006
An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyAaron R Folsom, Lloyd E Chambless, Christie M Ballantyne, et al.
Neurology|May 3, 2019
ApoB, small-dense LDL-C, Lp(a), LpPLA<sub>2</sub> activity, and cognitive changeYashashwi Pokharel, Farah Mouhanna, Vijay Nambi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changesHuaizhu Wu, John R Rodgers, Xiao-Yuan Dai Perrard, et al.
Vascular Medicine (London, England)|March 10, 2010
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery diseaseWilliam R Hiatt, Alan T Hirsch, Mark A Creager, et al.
The EMBO Journal|February 3, 2007
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrinValeria V Orlova, Eun Young Choi, Changping Xie, et al.
The American Journal of Medicine|May 20, 2019
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health SystemXiaoming Jia, Mahmoud Al Rifai, David J Ramsey, et al.
Journal of the American College of Cardiology|September 10, 2017
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysDonald M Lloyd-Jones, Pamela B Morris, Christie M Ballantyne, et al.
Journal of the American College of Cardiology|January 17, 2015
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registryRavi S Hira, Kevin Kennedy, Vijay Nambi, et al.
Magnetic Resonance Imaging|August 8, 2022
Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery diseaseAnkita Sinharoy, Neeti Reddy, John Kent Lin, et al.
Pageof 100